Literature DB >> 9089051

Corpus cavernosum electromyography (CC-EMG): a new technique in the diagnostic work-up of impotence.

F Sasso1, G Gulino, E Alcini.   

Abstract

We have studied cavernous electrical activity in 42 subjects, healthy volunteer controls and groups of impotent patients using a nonspecific electromyographic device (PICO-MENFIS) and a specific one, the SPACE-recorder 7500 designed to achieve electric recordings from the corpora cavernosa. In all of the patients, we detected under basal conditions a mean amplitude of 583 +/- 323 microV, a mean duration of 4.9 +/- 7 s, a mean polyphasicity of 3.5 +/- 1.4. It should be emphasized that a significant reduction of potential amplitudes was recorded after pharmacological stimulation in both the controls and the impotent patients. The healthy controls showed amplitudes significantly higher than the impotent patients after radical cystectomy (715 +/- 141 microV versus 381 +/- 227 microV, p < 0.01). The patients after a "nerve-sparing" radical cystectomy with a mean amplitude similar to the controls (500-700 microV) reacted well to the intracavernous drugs in a high percentage of cases. In our experience, CC-EMG seems to be a reliable method which can pinpoint directly lesions to the cavernous smooth muscle and penile autonomic nerves. It has also been able to assess the effects of stress, anxiety and pain on the erectile mechanisms.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9089051     DOI: 10.1007/bf02550732

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  15 in total

1.  Pudendal cortical somatosensory evoked potentials.

Authors:  R J Opsomer; J M Guerit; F X Wese; P J Van Cangh
Journal:  J Urol       Date:  1986-06       Impact factor: 7.450

2.  Studies on sacral-evoked potentials.

Authors:  R J Krane; M B Siroky
Journal:  J Urol       Date:  1980-12       Impact factor: 7.450

3.  RR interval variation and the sympathetic skin response in the assessment of autonomic function in peripheral neuropathy.

Authors:  B T Shahani; T J Day; D Cros; N Khalil; C S Kneebone
Journal:  Arch Neurol       Date:  1990-06

4.  Neuroanatomy of penile erection: its relevance to iatrogenic impotence.

Authors:  T F Lue; S J Zeineh; R A Schmidt; E A Tanagho
Journal:  J Urol       Date:  1984-02       Impact factor: 7.450

5.  In vivo recording of electrical activity of canine tracheal smooth muscle.

Authors:  T Kondo; K Tamura; K Onoe; H Takahira; Y Ohta; H Yamabayashi
Journal:  J Appl Physiol (1985)       Date:  1992-01

6.  Sacral signal tracing: the electrophysiology of the bulbocavernosus reflex.

Authors:  M B Siroky; D S Sax; R J Krane
Journal:  J Urol       Date:  1979-11       Impact factor: 7.450

7.  Standardized evaluation of erectile dysfunction in 95 consecutive patients.

Authors:  T C Gerstenberg; J Nordling; T Hald; G Wagner
Journal:  J Urol       Date:  1989-04       Impact factor: 7.450

8.  Single potential analysis of cavernous electrical activity in impotent patients: a possible diagnostic method for autonomic cavernous dysfunction and cavernous smooth muscle degeneration.

Authors:  C G Stief; M Djamilian; P Anton; W de Riese; E P Allhoff; U Jonas
Journal:  J Urol       Date:  1991-09       Impact factor: 7.450

9.  Penile sensory disorders in erectile dysfunction: results of a comprehensive neuro-urophysiological diagnostic evaluation in 123 patients.

Authors:  B L Bemelmans; E J Meuleman; B W Anten; W H Doesburg; P E Van Kerrebroeck; F M Debruyne
Journal:  J Urol       Date:  1991-09       Impact factor: 7.450

10.  Electrical activity of corpus cavernosum during flaccidity and erection of the human penis: a new diagnostic method?

Authors:  G Wagner; T Gerstenberg; R J Levin
Journal:  J Urol       Date:  1989-09       Impact factor: 7.450

View more
  1 in total

Review 1.  Cavernous smooth muscles: innovative potential therapies are promising for an unrevealed clinical diagnosis.

Authors:  Ahmed Mohamed Hassanin; Ahmed Zain Abdel-Hamid
Journal:  Int Urol Nephrol       Date:  2019-10-15       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.